Jupiter Neurosciences Presenting at the 3rd Annual DealFlow Discovery Conference

ECONOMY 27.01.2026

JUPITER, FL / ACCESS Newswire / January 27, 2026 / Jupiter Neurosciences, Inc. (NASDAQ:JUNS), a clinical-stage pharmaceutical company developing JOTROL™, a patented resveratrol-based platform for neuroinflammation and healthy aging, today announced that it will participate in the DealFlow Discovery Conference, taking place January 28-29, 2026.

Text size:

Christer Rosén, Chairman and CEO of Jupiter Neurosciences, will deliver a company presentation and be available for one-on-one investor meetings throughout the event. Learn more about Jupiter Neurosciences at www.jupiterneurosciences.com.

Event Details:

Conference: 3rd Annual DealFlow Discovery Conference
Venue: The Borgata Hotel, Casino & Spa
Location: Atlantic City, NJ
Date: January 28-29, 2026

Investors interested in scheduling a meeting with the Jupiter Neurosciences management team should request an investor pass to attend the conference (no cost to attend).

About Jupiter Neurosciences, Inc.

Jupiter Neurosciences is a clinical-stage pharmaceutical company pursuing a dual-path strategy to address neuroinflammation and promote healthy aging. The Company is advancing a therapeutic pipeline targeting central nervous system (CNS) disorders and rare diseases, while also expanding into the consumer longevity market with its Nugevia product line. Both efforts are powered by JOTROL™, Jupiter's proprietary, enhanced resveratrol formulation that has demonstrated significantly improved bioavailability. Nugevia brings clinical-grade science to the supplement space, supporting mental clarity, skin health, and mitochondrial function. The Company's prescription pipeline is focused broadly on CNS disorders, presently with a Phase IIa in Parkinson's disease, including indications such as Alzheimer's Disease, Mucopolysaccharidoses Type I, Friedreich's Ataxia, and MELAS.

Media Contact:

Christer Rosén
Chairman and CEO
Jupiter Neurosciences, Inc.
[email protected]

SOURCE: DealFlow Events

View the original press release on ACCESS Newswire

L.Mason--AMWN

SCS	0.12%	16.14	$
RBGPF	0.12%	82.5	$
CMSD	0.12%	24.08	$
CMSC	-0.04%	23.75	$
RYCEF	4.19%	16.7	$
RELX	-0.76%	35.53	$
BCC	1.15%	81.75	$
BCE	-0.12%	25.83	$
NGG	-0.78%	84.61	$
BTI	0.51%	60.99	$
GSK	1.66%	52.47	$
JRI	0.53%	13.15	$
RIO	1.61%	92.52	$
BP	-0.48%	37.7	$
VOD	1.74%	14.91	$
AZN	0.7%	188.41	$

American Marconi Wireless News - Jupiter Neurosciences Presenting at the 3rd Annual DealFlow Discovery Conference

Jupiter Neurosciences Presenting at the 3rd Annual DealFlow Discovery Conference

Featured

Equities, metals, oil rebound after Asia-wide rout

Italy's spread-out Olympics face transport challenge

Musk merges xAI into SpaceX in bid to build space data centers

New York records 13 cold-related deaths since late January